Yale Co-Leads New National Consortium for Rare Skin Disorders
Yale School of Medicine will co-lead a new national consortium for rare skin disorders, pooling patients and expertise across institutions.
Topic
Clinical Research
Topic
Clinical Research
Early Ivarmacitinib Response Predicts Durable AD Outcomes
A post hoc analysis finds patients with early improvement on ivarmacitinib sustain better atopic dermatitis outcomes, offering cl…
Personalized Melanoma Vaccine Holds 49% Recession Reduction at 5 Years
NYU Langone reports a therapeutic cancer vaccine sustained a 49 percent reduction in melanoma recurrence or progression at five y…
Cancer Research UK launches prevention study for high-risk skin cancer groups
Cancer Research UK has launched a new study seeking improved prevention strategies for people at highest risk of skin cancer, mov…